世界のがん（腫瘍）プロファイリング市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Cancer (Tumor) Profiling Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z1061 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥553,800 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥830,700 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,107,600 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、がん（腫瘍）プロファイリングのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（免疫測定法、NGS、質量分析、その他）、用途別市場規模（臨床、研究）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・がん（腫瘍）プロファイリングの市場動向 ・企業の競争状況、市場シェア ・がん（腫瘍）プロファイリングの種類別市場規模（免疫測定法、NGS、質量分析、その他） ・がん（腫瘍）プロファイリングの用途別市場規模（臨床、研究） ・がん（腫瘍）プロファイリングの北米市場規模2016-2027（アメリカ、カナダ） ・がん（腫瘍）プロファイリングのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・がん（腫瘍）プロファイリングのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・がん（腫瘍）プロファイリングの中南米市場規模2016-2027（メキシコ、ブラジル） ・がん（腫瘍）プロファイリングの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Illumina、Qiagen、Neogenomics Laboratories、HTG Molecular Diagnostics、Genomic Health、Caris Life Sciences、Helomics Corporation、Nanostring Technologies、Oxford Gene Technology、Ribomed Biotechnologies） ・結論

Market Analysis and Insights: Global Cancer (Tumor) Profiling Market
The global Cancer (Tumor) Profiling market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cancer (Tumor) Profiling market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cancer (Tumor) Profiling market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cancer (Tumor) Profiling market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cancer (Tumor) Profiling market.

Global Cancer (Tumor) Profiling Scope and Market Size
Cancer (Tumor) Profiling market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cancer (Tumor) Profiling market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Immunoassay
NGS
Mass Spectrometry
Others

Segment by Application
Clinical
Research

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Illumina
Qiagen
Neogenomics Laboratories
HTG Molecular Diagnostics
Genomic Health
Caris Life Sciences
Helomics Corporation
Nanostring Technologies
Oxford Gene Technology

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer (Tumor) Profiling Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Immunoassay
1.2.3 NGS
1.2.4 Mass Spectrometry
1.2.5 Others
1.3 Market by Application
1.3.1 Global Cancer (Tumor) Profiling Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Clinical
1.3.3 Research
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Cancer (Tumor) Profiling Market Perspective (2016-2027)
2.2 Cancer (Tumor) Profiling Growth Trends by Regions
2.2.1 Cancer (Tumor) Profiling Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cancer (Tumor) Profiling Historic Market Share by Regions (2016-2021)
2.2.3 Cancer (Tumor) Profiling Forecasted Market Size by Regions (2022-2027)
2.3 Cancer (Tumor) Profiling Industry Dynamic
2.3.1 Cancer (Tumor) Profiling Market Trends
2.3.2 Cancer (Tumor) Profiling Market Drivers
2.3.3 Cancer (Tumor) Profiling Market Challenges
2.3.4 Cancer (Tumor) Profiling Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Cancer (Tumor) Profiling Players by Revenue
3.1.1 Global Top Cancer (Tumor) Profiling Players by Revenue (2016-2021)
3.1.2 Global Cancer (Tumor) Profiling Revenue Market Share by Players (2016-2021)
3.2 Global Cancer (Tumor) Profiling Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cancer (Tumor) Profiling Revenue
3.4 Global Cancer (Tumor) Profiling Market Concentration Ratio
3.4.1 Global Cancer (Tumor) Profiling Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer (Tumor) Profiling Revenue in 2020
3.5 Cancer (Tumor) Profiling Key Players Head office and Area Served
3.6 Key Players Cancer (Tumor) Profiling Product Solution and Service
3.7 Date of Enter into Cancer (Tumor) Profiling Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Cancer (Tumor) Profiling Breakdown Data by Type
4.1 Global Cancer (Tumor) Profiling Historic Market Size by Type (2016-2021)
4.2 Global Cancer (Tumor) Profiling Forecasted Market Size by Type (2022-2027)

5 Cancer (Tumor) Profiling Breakdown Data by Application
5.1 Global Cancer (Tumor) Profiling Historic Market Size by Application (2016-2021)
5.2 Global Cancer (Tumor) Profiling Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Cancer (Tumor) Profiling Market Size (2016-2027)
6.2 North America Cancer (Tumor) Profiling Market Size by Type
6.2.1 North America Cancer (Tumor) Profiling Market Size by Type (2016-2021)
6.2.2 North America Cancer (Tumor) Profiling Market Size by Type (2022-2027)
6.2.3 North America Cancer (Tumor) Profiling Market Size by Type (2016-2027)
6.3 North America Cancer (Tumor) Profiling Market Size by Application
6.3.1 North America Cancer (Tumor) Profiling Market Size by Application (2016-2021)
6.3.2 North America Cancer (Tumor) Profiling Market Size by Application (2022-2027)
6.3.3 North America Cancer (Tumor) Profiling Market Size by Application (2016-2027)
6.4 North America Cancer (Tumor) Profiling Market Size by Country
6.4.1 North America Cancer (Tumor) Profiling Market Size by Country (2016-2021)
6.4.2 North America Cancer (Tumor) Profiling Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Cancer (Tumor) Profiling Market Size (2016-2027)
7.2 Europe Cancer (Tumor) Profiling Market Size by Type
7.2.1 Europe Cancer (Tumor) Profiling Market Size by Type (2016-2021)
7.2.2 Europe Cancer (Tumor) Profiling Market Size by Type (2022-2027)
7.2.3 Europe Cancer (Tumor) Profiling Market Size by Type (2016-2027)
7.3 Europe Cancer (Tumor) Profiling Market Size by Application
7.3.1 Europe Cancer (Tumor) Profiling Market Size by Application (2016-2021)
7.3.2 Europe Cancer (Tumor) Profiling Market Size by Application (2022-2027)
7.3.3 Europe Cancer (Tumor) Profiling Market Size by Application (2016-2027)
7.4 Europe Cancer (Tumor) Profiling Market Size by Country
7.4.1 Europe Cancer (Tumor) Profiling Market Size by Country (2016-2021)
7.4.2 Europe Cancer (Tumor) Profiling Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Cancer (Tumor) Profiling Market Size (2016-2027)
8.2 Asia-Pacific Cancer (Tumor) Profiling Market Size by Type
8.2.1 Asia-Pacific Cancer (Tumor) Profiling Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cancer (Tumor) Profiling Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cancer (Tumor) Profiling Market Size by Type (2016-2027)
8.3 Asia-Pacific Cancer (Tumor) Profiling Market Size by Application
8.3.1 Asia-Pacific Cancer (Tumor) Profiling Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cancer (Tumor) Profiling Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cancer (Tumor) Profiling Market Size by Application (2016-2027)
8.4 Asia-Pacific Cancer (Tumor) Profiling Market Size by Region
8.4.1 Asia-Pacific Cancer (Tumor) Profiling Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cancer (Tumor) Profiling Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Cancer (Tumor) Profiling Market Size (2016-2027)
9.2 Latin America Cancer (Tumor) Profiling Market Size by Type
9.2.1 Latin America Cancer (Tumor) Profiling Market Size by Type (2016-2021)
9.2.2 Latin America Cancer (Tumor) Profiling Market Size by Type (2022-2027)
9.2.3 Latin America Cancer (Tumor) Profiling Market Size by Type (2016-2027)
9.3 Latin America Cancer (Tumor) Profiling Market Size by Application
9.3.1 Latin America Cancer (Tumor) Profiling Market Size by Application (2016-2021)
9.3.2 Latin America Cancer (Tumor) Profiling Market Size by Application (2022-2027)
9.3.3 Latin America Cancer (Tumor) Profiling Market Size by Application (2016-2027)
9.4 Latin America Cancer (Tumor) Profiling Market Size by Country
9.4.1 Latin America Cancer (Tumor) Profiling Market Size by Country (2016-2021)
9.4.2 Latin America Cancer (Tumor) Profiling Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Cancer (Tumor) Profiling Market Size (2016-2027)
10.2 Middle East & Africa Cancer (Tumor) Profiling Market Size by Type
10.2.1 Middle East & Africa Cancer (Tumor) Profiling Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cancer (Tumor) Profiling Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cancer (Tumor) Profiling Market Size by Type (2016-2027)
10.3 Middle East & Africa Cancer (Tumor) Profiling Market Size by Application
10.3.1 Middle East & Africa Cancer (Tumor) Profiling Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cancer (Tumor) Profiling Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cancer (Tumor) Profiling Market Size by Application (2016-2027)
10.4 Middle East & Africa Cancer (Tumor) Profiling Market Size by Country
10.4.1 Middle East & Africa Cancer (Tumor) Profiling Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cancer (Tumor) Profiling Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Details
11.1.2 Illumina Business Overview
11.1.3 Illumina Cancer (Tumor) Profiling Introduction
11.1.4 Illumina Revenue in Cancer (Tumor) Profiling Business (2016-2021)
11.1.5 Illumina Recent Development
11.2 Qiagen
11.2.1 Qiagen Company Details
11.2.2 Qiagen Business Overview
11.2.3 Qiagen Cancer (Tumor) Profiling Introduction
11.2.4 Qiagen Revenue in Cancer (Tumor) Profiling Business (2016-2021)
11.2.5 Qiagen Recent Development
11.3 Neogenomics Laboratories
11.3.1 Neogenomics Laboratories Company Details
11.3.2 Neogenomics Laboratories Business Overview
11.3.3 Neogenomics Laboratories Cancer (Tumor) Profiling Introduction
11.3.4 Neogenomics Laboratories Revenue in Cancer (Tumor) Profiling Business (2016-2021)
11.3.5 Neogenomics Laboratories Recent Development
11.4 HTG Molecular Diagnostics
11.4.1 HTG Molecular Diagnostics Company Details
11.4.2 HTG Molecular Diagnostics Business Overview
11.4.3 HTG Molecular Diagnostics Cancer (Tumor) Profiling Introduction
11.4.4 HTG Molecular Diagnostics Revenue in Cancer (Tumor) Profiling Business (2016-2021)
11.4.5 HTG Molecular Diagnostics Recent Development
11.5 Genomic Health
11.5.1 Genomic Health Company Details
11.5.2 Genomic Health Business Overview
11.5.3 Genomic Health Cancer (Tumor) Profiling Introduction
11.5.4 Genomic Health Revenue in Cancer (Tumor) Profiling Business (2016-2021)
11.5.5 Genomic Health Recent Development
11.6 Caris Life Sciences
11.6.1 Caris Life Sciences Company Details
11.6.2 Caris Life Sciences Business Overview
11.6.3 Caris Life Sciences Cancer (Tumor) Profiling Introduction
11.6.4 Caris Life Sciences Revenue in Cancer (Tumor) Profiling Business (2016-2021)
11.6.5 Caris Life Sciences Recent Development
11.7 Helomics Corporation
11.7.1 Helomics Corporation Company Details
11.7.2 Helomics Corporation Business Overview
11.7.3 Helomics Corporation Cancer (Tumor) Profiling Introduction
11.7.4 Helomics Corporation Revenue in Cancer (Tumor) Profiling Business (2016-2021)
11.7.5 Helomics Corporation Recent Development
11.8 Nanostring Technologies
11.8.1 Nanostring Technologies Company Details
11.8.2 Nanostring Technologies Business Overview
11.8.3 Nanostring Technologies Cancer (Tumor) Profiling Introduction
11.8.4 Nanostring Technologies Revenue in Cancer (Tumor) Profiling Business (2016-2021)
11.8.5 Nanostring Technologies Recent Development
11.9 Oxford Gene Technology
11.9.1 Oxford Gene Technology Company Details
11.9.2 Oxford Gene Technology Business Overview
11.9.3 Oxford Gene Technology Cancer (Tumor) Profiling Introduction
11.9.4 Oxford Gene Technology Revenue in Cancer (Tumor) Profiling Business (2016-2021)
11.9.5 Oxford Gene Technology Recent Development
11.10 Ribomed Biotechnologies
11.10.1 Ribomed Biotechnologies Company Details
11.10.2 Ribomed Biotechnologies Business Overview
11.10.3 Ribomed Biotechnologies Cancer (Tumor) Profiling Introduction
11.10.4 Ribomed Biotechnologies Revenue in Cancer (Tumor) Profiling Business (2016-2021)
11.10.5 Ribomed Biotechnologies Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Cancer (Tumor) Profiling Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Immunoassay
Table 3. Key Players of NGS
Table 4. Key Players of Mass Spectrometry
Table 5. Key Players of Others
Table 6. Global Cancer (Tumor) Profiling Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Cancer (Tumor) Profiling Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Cancer (Tumor) Profiling Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Cancer (Tumor) Profiling Market Share by Regions (2016-2021)
Table 10. Global Cancer (Tumor) Profiling Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Cancer (Tumor) Profiling Market Share by Regions (2022-2027)
Table 12. Cancer (Tumor) Profiling Market Trends
Table 13. Cancer (Tumor) Profiling Market Drivers
Table 14. Cancer (Tumor) Profiling Market Challenges
Table 15. Cancer (Tumor) Profiling Market Restraints
Table 16. Global Cancer (Tumor) Profiling Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Cancer (Tumor) Profiling Market Share by Players (2016-2021)
Table 18. Global Top Cancer (Tumor) Profiling Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer (Tumor) Profiling as of 2020)
Table 19. Ranking of Global Top Cancer (Tumor) Profiling Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Cancer (Tumor) Profiling Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Cancer (Tumor) Profiling Product Solution and Service
Table 23. Date of Enter into Cancer (Tumor) Profiling Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Cancer (Tumor) Profiling Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Cancer (Tumor) Profiling Revenue Market Share by Type (2016-2021)
Table 27. Global Cancer (Tumor) Profiling Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Cancer (Tumor) Profiling Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Cancer (Tumor) Profiling Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Cancer (Tumor) Profiling Revenue Market Share by Application (2016-2021)
Table 31. Global Cancer (Tumor) Profiling Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Cancer (Tumor) Profiling Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Cancer (Tumor) Profiling Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Cancer (Tumor) Profiling Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Cancer (Tumor) Profiling Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Cancer (Tumor) Profiling Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Cancer (Tumor) Profiling Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Cancer (Tumor) Profiling Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Cancer (Tumor) Profiling Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Cancer (Tumor) Profiling Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Cancer (Tumor) Profiling Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Cancer (Tumor) Profiling Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Cancer (Tumor) Profiling Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Cancer (Tumor) Profiling Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Cancer (Tumor) Profiling Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Cancer (Tumor) Profiling Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Cancer (Tumor) Profiling Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Cancer (Tumor) Profiling Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Cancer (Tumor) Profiling Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Cancer (Tumor) Profiling Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Cancer (Tumor) Profiling Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Cancer (Tumor) Profiling Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Cancer (Tumor) Profiling Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Cancer (Tumor) Profiling Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Cancer (Tumor) Profiling Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Cancer (Tumor) Profiling Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Cancer (Tumor) Profiling Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Cancer (Tumor) Profiling Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Cancer (Tumor) Profiling Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Cancer (Tumor) Profiling Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Cancer (Tumor) Profiling Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Cancer (Tumor) Profiling Market Size by Country (2022-2027) & (US$ Million)
Table 63. Illumina Company Details
Table 64. Illumina Business Overview
Table 65. Illumina Cancer (Tumor) Profiling Product
Table 66. Illumina Revenue in Cancer (Tumor) Profiling Business (2016-2021) & (US$ Million)
Table 67. Illumina Recent Development
Table 68. Qiagen Company Details
Table 69. Qiagen Business Overview
Table 70. Qiagen Cancer (Tumor) Profiling Product
Table 71. Qiagen Revenue in Cancer (Tumor) Profiling Business (2016-2021) & (US$ Million)
Table 72. Qiagen Recent Development
Table 73. Neogenomics Laboratories Company Details
Table 74. Neogenomics Laboratories Business Overview
Table 75. Neogenomics Laboratories Cancer (Tumor) Profiling Product
Table 76. Neogenomics Laboratories Revenue in Cancer (Tumor) Profiling Business (2016-2021) & (US$ Million)
Table 77. Neogenomics Laboratories Recent Development
Table 78. HTG Molecular Diagnostics Company Details
Table 79. HTG Molecular Diagnostics Business Overview
Table 80. HTG Molecular Diagnostics Cancer (Tumor) Profiling Product
Table 81. HTG Molecular Diagnostics Revenue in Cancer (Tumor) Profiling Business (2016-2021) & (US$ Million)
Table 82. HTG Molecular Diagnostics Recent Development
Table 83. Genomic Health Company Details
Table 84. Genomic Health Business Overview
Table 85. Genomic Health Cancer (Tumor) Profiling Product
Table 86. Genomic Health Revenue in Cancer (Tumor) Profiling Business (2016-2021) & (US$ Million)
Table 87. Genomic Health Recent Development
Table 88. Caris Life Sciences Company Details
Table 89. Caris Life Sciences Business Overview
Table 90. Caris Life Sciences Cancer (Tumor) Profiling Product
Table 91. Caris Life Sciences Revenue in Cancer (Tumor) Profiling Business (2016-2021) & (US$ Million)
Table 92. Caris Life Sciences Recent Development
Table 93. Helomics Corporation Company Details
Table 94. Helomics Corporation Business Overview
Table 95. Helomics Corporation Cancer (Tumor) Profiling Product
Table 96. Helomics Corporation Revenue in Cancer (Tumor) Profiling Business (2016-2021) & (US$ Million)
Table 97. Helomics Corporation Recent Development
Table 98. Nanostring Technologies Company Details
Table 99. Nanostring Technologies Business Overview
Table 100. Nanostring Technologies Revenue in Cancer (Tumor) Profiling Business (2016-2021) & (US$ Million)
Table 101. Nanostring Technologies Recent Development
Table 102. Oxford Gene Technology Company Details
Table 103. Oxford Gene Technology Business Overview
Table 104. Oxford Gene Technology Cancer (Tumor) Profiling Product
Table 105. Oxford Gene Technology Revenue in Cancer (Tumor) Profiling Business (2016-2021) & (US$ Million)
Table 106. Oxford Gene Technology Recent Development
Table 107. Ribomed Biotechnologies Company Details
Table 108. Ribomed Biotechnologies Business Overview
Table 109. Ribomed Biotechnologies Cancer (Tumor) Profiling Product
Table 110. Ribomed Biotechnologies Revenue in Cancer (Tumor) Profiling Business (2016-2021) & (US$ Million)
Table 111. Ribomed Biotechnologies Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cancer (Tumor) Profiling Market Share by Type: 2020 VS 2027
Figure 2. Immunoassay Features
Figure 3. NGS Features
Figure 4. Mass Spectrometry Features
Figure 5. Others Features
Figure 6. Global Cancer (Tumor) Profiling Market Share by Application: 2020 VS 2027
Figure 7. Clinical Case Studies
Figure 8. Research Case Studies
Figure 9. Cancer (Tumor) Profiling Report Years Considered
Figure 10. Global Cancer (Tumor) Profiling Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Cancer (Tumor) Profiling Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Cancer (Tumor) Profiling Market Share by Regions: 2020 VS 2027
Figure 13. Global Cancer (Tumor) Profiling Market Share by Regions (2022-2027)
Figure 14. Global Cancer (Tumor) Profiling Market Share by Players in 2020
Figure 15. Global Top Cancer (Tumor) Profiling Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer (Tumor) Profiling as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Cancer (Tumor) Profiling Revenue in 2020
Figure 17. Global Cancer (Tumor) Profiling Revenue Market Share by Type (2016-2021)
Figure 18. Global Cancer (Tumor) Profiling Revenue Market Share by Type (2022-2027)
Figure 19. North America Cancer (Tumor) Profiling Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Cancer (Tumor) Profiling Market Share by Type (2016-2027)
Figure 21. North America Cancer (Tumor) Profiling Market Share by Application (2016-2027)
Figure 22. North America Cancer (Tumor) Profiling Market Share by Country (2016-2027)
Figure 23. United States Cancer (Tumor) Profiling Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Cancer (Tumor) Profiling Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Cancer (Tumor) Profiling Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Cancer (Tumor) Profiling Market Share by Type (2016-2027)
Figure 27. Europe Cancer (Tumor) Profiling Market Share by Application (2016-2027)
Figure 28. Europe Cancer (Tumor) Profiling Market Share by Country (2016-2027)
Figure 29. Germany Cancer (Tumor) Profiling Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Cancer (Tumor) Profiling Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Cancer (Tumor) Profiling Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Cancer (Tumor) Profiling Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Cancer (Tumor) Profiling Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Cancer (Tumor) Profiling Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Cancer (Tumor) Profiling Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Cancer (Tumor) Profiling Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Cancer (Tumor) Profiling Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Cancer (Tumor) Profiling Market Share by Region (2016-2027)
Figure 39. China Cancer (Tumor) Profiling Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Cancer (Tumor) Profiling Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Cancer (Tumor) Profiling Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Cancer (Tumor) Profiling Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Cancer (Tumor) Profiling Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Cancer (Tumor) Profiling Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Cancer (Tumor) Profiling Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Cancer (Tumor) Profiling Market Share by Type (2016-2027)
Figure 47. Latin America Cancer (Tumor) Profiling Market Share by Application (2016-2027)
Figure 48. Latin America Cancer (Tumor) Profiling Market Share by Country (2016-2027)
Figure 49. Mexico Cancer (Tumor) Profiling Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Cancer (Tumor) Profiling Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Cancer (Tumor) Profiling Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Cancer (Tumor) Profiling Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Cancer (Tumor) Profiling Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Cancer (Tumor) Profiling Market Share by Country (2016-2027)
Figure 55. Turkey Cancer (Tumor) Profiling Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Cancer (Tumor) Profiling Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Cancer (Tumor) Profiling Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Illumina Revenue Growth Rate in Cancer (Tumor) Profiling Business (2016-2021)
Figure 59. Qiagen Revenue Growth Rate in Cancer (Tumor) Profiling Business (2016-2021)
Figure 60. Neogenomics Laboratories Revenue Growth Rate in Cancer (Tumor) Profiling Business (2016-2021)
Figure 61. HTG Molecular Diagnostics Revenue Growth Rate in Cancer (Tumor) Profiling Business (2016-2021)
Figure 62. Genomic Health Revenue Growth Rate in Cancer (Tumor) Profiling Business (2016-2021)
Figure 63. Caris Life Sciences Revenue Growth Rate in Cancer (Tumor) Profiling Business (2016-2021)
Figure 64. Helomics Corporation Revenue Growth Rate in Cancer (Tumor) Profiling Business (2016-2021)
Figure 65. Nanostring Technologies Revenue Growth Rate in Cancer (Tumor) Profiling Business (2016-2021)
Figure 66. Oxford Gene Technology Revenue Growth Rate in Cancer (Tumor) Profiling Business (2016-2021)
Figure 67. Ribomed Biotechnologies Revenue Growth Rate in Cancer (Tumor) Profiling Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

---